KRAS and exocrine pancreatic carcinoma: Moreover GPD inhibited the anchorage-independent cell growth in PANC-1 pancreatic carcinoma in a dose-dependent manner (Figure S1) which cells possess overactivated C-Raf due to activated K-Ras mutation instead of B-Raf mutation.